CORONA Remedies Limited has informed the Exchange regarding 'Intimation of violation under the Company''s Code of Conduct for Regulating, Monitoring and Reporting of Insider Trading in securities and the SEBI (Prohibition of Insider Trading) Regulations, 2015'.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Corona Remedies Limited has informed the stock exchange about a violation of its internal Code of Conduct for Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has self-reported this violation to the exchange as required under insider trading rules. The identity of the violator, the nature of the violation, and the specific securities involved have not been disclosed in this headline. Such intimations typically follow when the company identifies that an insider has traded in shares during a restricted period or without proper pre-clearance. The company will likely take disciplinary action and may be required to report the matter to SEBI.
This is a governance red flag for shareholders. Depending on the severity and scale of the violation, it could lead to SEBI action, fines, or reputational damage, potentially weighing on the stock in the short term. Investors should watch for further disclosures detailing the nature of the violation and any penalties imposed.